Oxidation of low-density lipoprotein (LDL) is thought to be a major factor in the pathophysiology of atherosclerosis. Elevated plasma homocysteine is an accepted risk factor for atherosclerosis, and may act through LDL oxidation, although this is controversial. In this study, homocysteine at physiological concentrations is shown to act as a pro-oxidant for three stages of copper-mediated LDL oxidation (initiation, conjugated diene formation and aldehyde formation), whereas at high concentration, it acts as an antioxidant. The affinity for copper of homocysteine and related copper ligands homocysteine, cystathionine and djenkolate was measured, showing that at high concentrations (100 AM) under our assay conditions, they bind essentially all of the copper present. This is used to rationalise the behaviour of these ligands, which stimulate LDL oxidation at low concentration but generally inhibit it at high concentration. Albumin strongly reduced the effect of homocystine on lag time for LDL oxidation, suggesting that the effects of homocystine are due to copper binding. In contrast, copper binding does not fully explain the pro-oxidant behaviour of low concentrations of homocysteine towards LDL, which appears in part at least to be due to stimulation of free radical production. The likely role of homocysteine in LDL oxidation in vivo is discussed in the light of these results. D
Introduction
There is a well-established epidemiological relationship between total plasma homocysteine concentration (tHcy) and cardiovascular disease [1] [2] [3] [4] . It has been estimated that 10% of the population risk for cardiovascular disease in the US is associated with elevated tHcy [5] . Elevated tHcy is linked to increased risk of cardiovascular disease to a similar extent to that of smoking and hyperlipidaemia, and strengthens the link between smoking and hypertension [6] . Various explanations have been put forward to account for these associations, including a pro-oxidant role for tHcy in vivo. It has been hypothesised for example that tHcy stimulates the oxidation of low-density lipoprotein (LDL) lipid. Oxidatively damaged LDL are considered atherogenic.
The oxidised lipid would tend to form atherosclerotic plaques and so promote cardiovascular disease. The evidence for or against this hypothesis is confused. A number of studies, primarily in vitro, suggest that tHcy does promote oxidation of LDL [7] [8] [9] [10] [11] [12] [13] [14] [15] . Other studies, however, suggest that tHcy does not promote oxidation of LDL, and may even act to protect LDL against oxidation [16 -18] . Interpretation of the results of these studies is complicated by the fact that in vivo (and in in vitro assays) most homocysteine (HcySH) is rapidly oxidised to homocystine (HcySS) or to mixed disulfides, leaving only approximately 1% as free HcySH [19] .
Neither the site of oxidative damage to LDL nor the mechanisms involved in vivo are understood. The majority of studies of LDL oxidation in vitro [10, 20, 21] have used transition metal-dependent (usually copper) systems, although some have used organic free radical generators [22] or enzymatic systems [23] . We concentrate here on the role of homocysteine and related compounds on coppermediated oxidation. A complex set of reactions is involved, which requires thiol-dependent reduction of copper [24] , and include at least the following [25, 26] :
The reactive oxygen species (ROS) so produced then oxidise LDL. LDL is made up of protein and lipid, which latter contains a number of small molecules including cholesterol and tocopherol (vitamin E). In this study, we concentrate on oxidation of the lipid component. There is general agreement that the first stage in oxidation of LDL lipid is oxidation of tocopherol and carotenoids [27, 28] . Following this stage, polyunsaturated fatty acids are oxidised to conjugated dienes. Further oxidation leads to the formation of the peroxyl radical which goes on to form lipid hydroperoxides (and cyclic peroxides) which can decompose to form aldehydes, including malondialdehyde (MDA) [29] . Compounds which lengthen the period preceding the maximum rate of peroxidation (the 'lag phase') are considered as antioxidants. LDL lipid peroxidation can be monitored in vitro in a number of ways, including the measurement of conjugated dienes, and MDA formation. Lag times for diene and aldehyde formation have often been found to be similar [30, 31] . The complexity of these reactions, particularly in plasma, where there are many other molecules present that may interfere, means that different researchers have come to very different conclusions about the effects of homocysteine towards LDL. We therefore concentrate here on exploring a simple but moderately realistic system, to show how LDL oxidation is affected by homocysteine and other related compounds, and the putative mechanisms involved.
Materials and methods

Materials
Chemicals were purchased from Sigma Chemical Co., Poole, Dorset, UK except where stated otherwise.
LDL preparation
Fasted blood was collected from a healthy volunteer into lithium heparin, and centrifuged at 4 jC at 1000 Â g for 15 min to remove cells. LDL was isolated from the plasma by centrifugation through iodixanol (Liposep, Lipotek Ltd., Liverpool, UK), using a method modified from Graham et al. [32] . Plasma was mixed with iodixanol in Hepes-buffered saline (HBS) (0.14 M NaCl, 10 mM Hepes, pH 7.4) to make a 12% iodixanol solution. This was layered underneath a 9% iodixanol solution and centrifuged for 2.5 h at 16 jC at 100,000 rpm in an Optima Max-E centrifuge. The fractions containing LDL were separated using a Gilson FC 205 fraction collector and pooled. At this stage, fractions could be flushed with nitrogen and kept at 4 jC until use for at least a week without any measurable increase in lipid oxidation, measured as diene formation. To remove iodixanol and low molecular weight endogenous antioxidants, the solution was passed under gravity flow through a 1.0 Â 30 cm column of Sephadex G-25, eluted with HBS. The cholesterol concentration of the isolated LDL preparation was measured using a cholesterol oxidase assay.
LDL lipid oxidation
For LDL oxidation assays, all LDL preparations were diluted with HBS to 100 Ag LDL protein/ml (162 Ag cholesterol/ml). Oxidation was initiated by the addition of CuSO 4 (final Cu concentration 30 AM), approximating that in plasma [33] , and sodium citrate (final concentration 360 AM), and carried out at 37 jC. These conditions were designed to approximate in vivo copper availability (see Discussion). The total time between passage through the Sephadex column and start of the incubation with copper was less than 1 h.
Oxidation of LDL lipids to conjugated dienes was measured by continuous monitoring of the absorbance at 234 nm [34] . The LDL suspension was incubated in a quartz cuvette, and the absorbance measured at 234 nm against a blank of HBS, using a Camspec M330 single beam UV/ Visible spectrophotometer operating at 37 jC. The molar concentration of diene present was calculated using a molar extinction coefficient of 2.52 Â 10 4 M À 1 cm À 1 [34] . Oxidation of LDL to MDA was measured by monitoring the product of reaction with thiobarbituric acid, using the TBARS assay [18, 34] . All incubations were carried out in 1.5 ml screw-capped Eppendorf tubes, in a volume of 0.4 ml. After the incubation of LDL, butylated hydroxytoluene (final concentration, 500 AM) and diethylenetriaminepentaacetic acid (DTPA) (final concentration, 1 mM) were added to prevent further oxidation. A stock solution of 15% w/v trichloroacetic acid, 0.38% w/v thiobarbituric acid, and 0.25 N hydrochloric acid was prepared, and 0.8 ml of this was added to the LDL suspension, which was heated for 15 min at 100 jC. The suspension was then cooled and centrifuged at 13,000 rpm, 4 jC for 5 min. The resulting clear solution (ca. 0.8 ml) was placed in a cuvette, the absorbance at 532 and 580 nm was measured, and the difference in absorbance (A 532 -A 580 ) determined. Concentrations of MDA were calculated using an extinction coefficient of 1.56 Â 10 5 M À 1 cm À 1 [18] .
LDL lipid oxidation, measured as dienes or TBARS, was plotted as a function of incubation time. The kinetics of LDL lipid oxidation were analysed in terms of the lag time prior to oxidation, using the graphical method of McDowell et al. [31] , implemented in a macro specially written for the Camspec. The tangent to the curve was taken at the steepest part of the slope, and extrapolated back to the baseline absorbance. The baseline absorbance was taken as the absorbance preceding the steep rise in absorbance.
Effects of homocysteine and related compounds on LDL oxidation
L-Homocysteine was prepared from L-homocysteine thiolactone [35] . Homocysteine thiolactone (0.05 mmol) was mixed with 0.15 ml of 5 M NaOH and incubated for 5 min at room temperature. 0.75 ml of 1.0 M KH 2 PO 4 was added to the solution and diluted to a volume of 10 ml with water, to give a stock solution of 5 mM homocysteine at neutral pH, which was stored under N 2 at À 20 jC. The solution was diluted in HBS to 1 mM before use. Homocysteine was added to the LDL suspension immediately before oxidation was initiated with copper, to a final homocysteine concentration of 5, 10, 50 and 100 AM. In order to explain observed effects of homocysteine on LDL oxidation, experiments were also carried out in the presence of L-homocystine, DL-djenkolate and L-cystathionine, all of which are potential copper ligands. These compounds were made up as stock solutions in 1 M HCl, because of their low solubility at neutral pH, and added to the LDL reaction mixture to give final concentrations of 10 and 100 AM. The resultant change in pH was less than 0.1 pH units and is calculated (Hyperquad2000) to have negligible effect on copper binding.
Copper-binding affinities of homocysteine and related compounds (ligands)
The most convenient way to measure copper-binding affinities is to measure pK values in the absence of copper, and then repeat the measurement in the presence of copper. Copper competes with H + for binding to the ligand, and therefore affects the pK. Binding affinities can be obtained by fitting the pK titration curve.
Affinities for copper were measured by pH titration of the ligand starting from pH < 2 and titrating with 1 M sodium hydroxide. Ligand concentrations were 4 mM in 10 ml, except where insolubility at pH>6 necessitated reducing the concentration to 1, 0.5 or 0.1 mM: in this case, the sodium hydroxide concentration was also reduced. Measured pH values were fitted to a model involving three (citrate, cystathionine, HcySH) or four (djenkolate, HcySS) pK values: inclusion of additional pK values where relevant gave worse fits. Titrations were then repeated in the presence of equimolar concentrations of copper. The fitting used the pK values in the absence of copper as fixed, and included Cu.L, H.Cu.L (all), H 2 .Cu.L (cystathionine, djenkolate, homocystine), L 2 .Cu (all except citrate and djenkolate) as the species present: again, addition of extra species gave worse fits. All fitting and subsequent speciation calculations were done using the program Hyperquad2000 [36] .
Statistical analysis
Statistical tests were carried out using SPSS for Windows 10.0. Because of the small number of experiments for each set of conditions (generally four or five), non-parametric tests were used. The Kruskal -Wallis test was used to determine whether homocysteine concentration influenced lag times, after which the Mann -Whitney U-test was used to compare specific pairs of conditions. A post hoc Tukey one-way ANOVA gave similar results. As data are not normally distributed, they are displayed as medians and ranges.
Results
Copper-mediated LDL oxidation
Previous workers have suggested that the LDL preparation has to be as fresh as possible, without hydroperoxides [31] , and that the copper should be chelated reasonably strongly, since a simple hydrated copper ion binds preferentially to phosphate, chloride, etc., which leads to markedly different oxidation rates with small changes in buffer composition [37] . On the other hand, chelation by a tight ligand such as EDTA reduces the oxidation rate strongly [31] . We therefore followed Schnitzer et al. [14, 37] and used citrate in the assay buffer, which binds copper moderately tightly and prevents precipitation. We also used a method for purifying LDL that takes less than 5 h from collection of blood. Partially purified samples could be kept at 4 jC under nitrogen for several days without any obvious effect. For most measurements, storage at 4 jC for a week gave little if any change in the lag time ( Fig. 1A) . By far the most marked time dependence was seen for measurements made in the presence of 100 AM HcySS, where storage even for 2 days gave a large reduction in lag time (Fig. 1B) . Most measurements were therefore carried out within 3 days of blood collection. The final purification step, involving rapid gel filtration chromatography, was always carried out within 1 h of starting the assay. When LDL was prepared in this way, the lag time was approximately 125 min, and varied by no more than 10 min from one preparation to another, in fasted blood samples from the same individual. On leaving the LDL for 2 h between the removal of endogenous antioxidants by Sephadex chromatography and the start of the incubation, the lag time decreased to approximately 70 min, indicating that significant oxidation occurs even over this short time in the absence of copper once low molecular weight antioxidants have been removed. Fig. 2A shows the kinetics for the copper-mediated oxidation of LDL lipid measured using the conjugated diene assay, over a range of concentrations of HcySH from 0 to 100 AM. Typical of LDL oxidation, there was a lag time, during which absorbance increased slowly, followed by a rapid increase to a maximum value. The typical maximum change in absorbance was approximately 1.2 AU, which corresponds to a change in concentration of conjugated diene of ca. 47 AM. The estimated total concentration of polyunsaturated fatty acid in this LDL preparation was 42 AM, based on typical LDL compositions [38] , and therefore the change seen suggests that essentially all the polyunsaturated fatty acid present has been oxidised to conjugated diene. A slow subsequent loss in signal intensity at low concentrations of HcySH presumably reflects further oxidation of conjugated dienes [16, 39] . It is clear that lag times vary markedly as a function of HcySH concentration, but so do the times for the complete oxidation to dienes, which show a small reduction at low (HcySH) followed by an increase at higher concentration (Fig. 2B ). Fig. 3A shows profiles for MDA formation during LDL oxidation in the presence of different concentrations of HcySH. The general oxidation profile is similar to that of the conjugated diene ( Fig. 2A) . The maximum change in absorbance was approximately 0.3 AU, corresponding to a concentration change of 6 AM. MDA is thought to be produced almost entirely from tri-unsaturated fatty acids [34] , which on the basis of the average composition of LDL, have an estimated concentration in this preparation of approximately 8 AM and consist almost entirely of linolenic acid [38] .
Effects of homocysteine on LDL oxidation
Oxidation to conjugated diene
Oxidation to malondialdehyde
The lag times for oxidation of LDL lipid to conjugated diene and TBARS were calculated, and are shown in Table  1 and compared in Fig. 3B . Effects of homocysteine were qualitatively similar for both stages of lipid oxidation in that low concentrations (5 and 10 AM) speeded up oxidation while higher concentrations (50 and 100 AM) slowed down oxidation. Diene formation in the presence of all concentrations of homocysteine was significantly different from the control ( P < 0.05). The formation of TBARS at 10, 50 and 100 AM homocysteine was significantly different from the control ( P < 0.05), while 5 AM just failed to reach statistical significance ( P = 0.059). Higher concentrations of homocysteine had a more marked effect on the lag times for formation of TBARS than for conjugated dienes, suggesting that the oxidation of dienes to MDA and other aldehydes is inhibited by high concentrations of HcySH. The time taken for this stage is simply the time difference between the lag times for the conjugated diene and TBARS assays, and is shown in Fig. 4 .
Effect of homocystine, cystathionine and djenkolate
Most homocyst(e)ine in the circulation exists in oxidised forms, with only about 1% found as free HcySH, but with an increasing proportion in the reduced form as total concentrations rise [40, 41] . We therefore measured the effect of HcySS/HcySH mixtures on LDL oxidation, as measured by the lag time in conjugated diene assays. Homocystine had a marked effect on the lag time, which in general was reduced at 10 AM HcySS and greatly increased at 100 AM ( Table 2 ). These results are nonintuitive, and therefore to further explore the likely mechanisms of the effects of HcySH and HcySS, we carried out measurements using cystathionine [HO 2 C-CH(NH 2 )-CH 2 -CH 2 -S-CH 2 -CH(NH 2 )-CO 2 H] or djenkolate [HO 2 C-CH(NH 2 )-CH 2 -S-CH 2 -S-CH 2 -CH(NH 2 )-CO 2 H], since these compounds are similar in structure to HcySS but cannot be reduced to thiols or allow the formation of RSSRV À S radical anion. Cystathionine and djenkolate also had complex effects on the lag time (Table 3) , with both compounds producing a shorter lag time at 10 AM and djenkolate producing a longer lag time at 100 AM. (4) Values in parentheses indicate the number of measurements. Fig. 4 . Effects of homocysteine at different concentrations on the lag times for copper-mediated oxidation of LDL lipid from conjugated diene to MDA using data from Fig. 3B . This is expressed as the difference between the median lag times for absorbance at 234 nm and TBARS, with the upper and lower limits. Results are given as medians and ranges of between three and seven independent measurements. 
Copper affinities of homocysteine, homocystine, cystathionine and djenkolate
Cystathionine and djenkolate are most likely to affect the lag time for LDL oxidation via binding to copper, since they are expected to be unreactive in redox chemistry but have strong affinity for copper. We therefore measured the affinity for copper(II) of HcySH, HcySS, cystathionine, and djenkolate. This was done in the standard way, namely by measuring the effect of copper on pK values. Each compound was adjusted to low pH with HCl, and titrated with NaOH. The values of pH against volume of NaOH added (Fig. 5A ) were used to fit pK values ( Table 4 ). The titration was then repeated in the presence of equimolar amounts of Cu 2 + (Fig. 5B ). The previously fitted pK values were kept constant, and the curves were fitted to obtain values of the copper affinities for each complex, shown in Table 4 as the log of the association constant for each complex. These results are approximate, since a limited range of concentrations was used, and many of the fitted values are highly correlated. However, the fitted values are reasonably self-consistent, and where literature values are available [42] , the match is good.
Effect of albumin
The results reported in Tables 2 -4 demonstrate that HcySH, HcySS and its analogs bind strongly to copper and also affect the lag time for LDL oxidation. In vivo, most copper is bound to ceruloplasmin and albumin [43] . Addition of albumin at normal in vivo concentrations (30 -45 mg/ml) causes so much background signal that our assays of LDL oxidation could not be used. We therefore used a much lower albumin concentration, 0.5 mg/ml. Even at these low concentrations, there are effects on lag times in the presence of HcySH and particularly of HcySS (Table 5 ). In the absence of HcySS, albumin acts merely to increase the lag time. However, in the presence of HcySS, albumin appears to act to moderate the effect of HcySS, by altering the lag time in the direction of that seen in the absence of HcySS. Fig. 5. (A) pH Titration curve of cystathionine. Cystathionine (1 mM) in 10 ml dilute HCl was titrated with 1 M NaOH. Experimental points are shown by diamonds, and the fitted curve is shown, with the fitted values given in Table 1 . The x coordinates describe additions of NaOH, which were not all of the same volume. (B) Titration curve of 1 mM cystathionine, 1 mM copper sulfate with 1 M NaOH. Measurements of control, 10 and 100 AM were made on the same sample at the same time, and repeated two or three times on different samples to obtain the results quoted in the table. Results are given as medians and ranges.
Discussion
Three phases of LDL lipid oxidation
Almost all studies of LDL lipid oxidation have observed a lag phase [39, 44] , which is considered to reflect the period of depletion of endogenous antioxidants [28, 45] , as well as a period of autocatalytic formation of lipid peroxides, which are thought to be key initiators of subsequent oxidative steps [46, 47] . Here we have shown clearly for the first time that, as expected, the formation of conjugated dienes is a clearly differentiated step that precedes the formation of TBARS. Further, we have shown that HcySH at concentrations V 10 AM shortens the lag time for each phase, while at concentrations >10 AM it increases the lag time. Under the conditions of our assay, HcySH clearly behaves as a prooxidant at concentrations < 10 AM, and an antioxidant at higher concentrations.
This behaviour is similar to that observed by Halvorsen et al. [22] , but different from that seen in most other studies. There are several explanations. Some studies merely measured the amount of conjugated diene produced after 24h oxidation [7, 8, 10] . As can be seen from Fig. 2A , this is likely to produce misleading results, because whatever the lag time of LDL lipid oxidation, the maximal change in absorbance is always approximately the same. However, after reaching its maximum, absorbance at 234 nm slowly falls because of further oxidation and loss of conjugated dienes. Therefore, a single measurement made at 24 h may in fact give a smaller absorbance value for a faster oxidation. The use of citrate to bind to copper (discussed below) and very rapidly purified LDL in our experiments may also be a factor explaining the difference between our results and some others. Most previous studies have used much longer LDL preparation times, probably associated with significant oxidation before the start of incubation. This would make further oxidation harder to interpret, and could lead to problems from autocatalytic oxidation of LDL lipid [48, 49] . One of the few other studies to see an inhibition of LDL oxidation by homocysteine (at 1000 AM) also used a very rapid LDL preparation, resulting in unoxidised LDL at the start of incubation [50] . Storage of LDL evidently does influence susceptibility to oxidation in vitro, but this was particularly evident only in the presence of 100 AM HcySS. Our storage times were short and results were reproducible, suggesting that our LDL preparations were reasonably free from hydroperoxide.
Copper chelation
Cystathionine and djenkolate can only have any effect on LDL oxidation by binding to copper, and, assuming that there is nothing in the incubation buffer that can reduce it to homocysteine, homocystine can also only act by binding to copper. The results in Table 4 , taken together with results shown in Tables 2-3, show that binding to copper has major effects on the lag time for conjugated diene formation. At high concentrations (100 AM), homocystine and djenkolate lead to an increase in lag time. At these concentrations, over 95% of the copper is bound into complexes (calculated using the fitted association constants by Hyperquad2000 [36] ). It has been shown that binding of EDTA to copper results in a marked slowing of copper-mediated LDL oxidation [31] , and it would not be surprising if binding to other ligands had a similar effect.
The favourable free energy of binding copper to a ligand also makes the reduction of copper(II) to copper(I) less favourable, as shown by a thermodynamic cycle (Fig. 6 ). Thus, ligand binding of copper not only makes copper less available for oxidation reactions, it also makes it harder to reduce copper.
However, we have also found that 10 AM concentrations of homocystine, djenkolate or cystathionine reduce the lag time for production of conjugated dienes. At 10 AM ligand, approximately 10% of the copper present is free, and the remainder is distributed among a range of complexes. There is nothing in the nature of the complexes to explain the decrease in lag time. A number of hypotheses can be put forward to explain the results. One of the suggested subsequent reactions is the generation of ROS, for example by reactions of the type
where X represents one of the negatively charged ligands homocystine, djenkolate or cystathionine. It is likely that the ligands, by stabilising the more coulombically favourable X.Cu 2 + complex, promote the formation of ROS and thus reduce the lag time.
Copper chelation can therefore have major effects on the rate of LDL oxidation, either reducing or increasing it. This supports the findings of previous workers, who found that one source of confusion in earlier experiments was the lack of chelating species in the buffer, with the result that, for example, chloride in the buffer bound to Cu 2 + and Cu + differentially, thereby affecting oxidation rates [37] . For this Fig. 6 . Thermodynamic cycle for copper reduction and ligand binding. The total change in free energy from upper left to lower right is independent of the pathway taken, implying that the relatively strong binding of the more highly charged Cu 2 + to X À necessitates a less energetically favourable reduction of Cu 2 + .X À to Cu + .X À than of Cu 2 + to Cu + . reason, we used a reasonably weak copper ligand, citrate, at a high concentration [14] . In the absence of homocysteine, addition of citrate caused an increase in lag time (data not shown), consistent with citrate complexing to copper [37] . Furthermore, lag times measured using conjugated diene and MDA assays in the absence of citrate followed no logical or consistent pattern (data not shown), whereas in the presence of citrate the lag times are readily interpretable.
Effect of albumin and homocysteine on LDL oxidation
Homocysteine causes a decrease in lag time at low concentration and an increase at high concentration. Similar effects are produced by homocystine and djenkolate. The question therefore arises: are the effects of homocysteine due merely to copper binding, and not to free radical mechanisms? We have three reasons for thinking that free radical mechanisms are responsible.
First, there is extensive evidence that free radicals and ROS are formed during incubations of LDL with transition metals, and that the oxidative damage is consistent with the presence of free radicals [7, 20, 51] . Second, homocysteine has only relatively weak binding to copper. From the binding constants measured (Table 4 ) and the concentrations used in the assay, we calculate that when only copper and citrate are present, 11% of the copper is free and 89% is in the form of a copper -citrate complex. When 10 AM homocysteine is added, there is a modest reduction in the amount of the copper -citrate complex, to 86%, and 3% of the copper is present as a Cu.homocysteine.H 2 complex.
The third reason derives from the results of LDL oxidation in the presence of 0.5 mg/ml albumin. Albumin binds copper, and should reduce the influence of copper binding on LDL oxidation. In agreement with this, albumin substantially reduces the effect of HcySS on lag time, even when it is only present at 0.5 mg/ml ( Table 5 ). By contrast, it has little influence on the effect of HcySH, merely leading to an increase in the lag time, most likely due to chelation of free copper [44] . Thus, it has a much greater influence over effects clearly ascribable to copper binding than it does on HcySH, implying that HcySH does not act merely through copper binding.
Relevance to the in vivo situation
What do these results tell us about the role of homocyst(e)ine in vivo? In healthy individuals, the plasma total homocyst(e)ine range is 5-15 AM, of which the concentration of homocysteine itself is only about 1% [41] . A moderate elevation in plasma homocysteine (15 -50 AM) of various etiology has been associated with an increased risk of premature cardiovascular disease in the general population [52] . In subjects homozygous for cystathione h synthase deficiency, for whom there is an increased risk of cardiovascular disease, the total homocyst(e)ine concentration commonly rises over 200 AM and the homocysteine concentration over 10 AM [40] . The concentration of copper in plasma is similar to that used here, but 95% of it is bound by ceruloplasmin, most of the rest being bound by albumin [44] . However, it has been shown that ceruloplasmin-bound copper behaves very similarly to copper in simple complexes (for example, complexes with citrate, as used here), possibly because in ceruloplasmin one of the eight bound copper atoms is accessible to the surface and is therefore available for redox reactions [53, 54] . Thus, although most of our experiments did not use ceruloplasmin or albumin to bind copper, the use of citrate is a reasonably physiological surrogate. Extrapolating from our results with albumin, the Cu-binding effect of homocystine in plasma is therefore likely to be insignificant, and consequently homocystine is unlikely to influence LDL oxidation in vivo. We conclude that the conditions of our assay are sufficiently close to the in vivo conditions for the results to be relevant. We find that in concentrations up to 10 AM (i.e., over all the range accessible in vivo), homocysteine acts as a pro-oxidant for LDL. This agrees with the majority of studies of homocysteine [7 -15] , and supports the hypothesis that homocysteine is an independent risk factor for cardiovascular disease because it stimulates oxidation of LDL lipid [55] .
The major thiol in plasma is cysteine, which is present at concentrations approximately 10 times greater than homocysteine. The work described here is therefore only of relevance if homocysteine is chemically distinct from cysteine. Recent work [56, 57] suggests that the two compounds have interlinked roles, but with different reactivity and redox potential, leading to a marked differentiation of activity. Reduced homocysteine is exported continuously in low concentration from endothelial cells, which may be an important factor in distinguishing its physiological relevance to cardiovascular disease from effects of cysteine.
